| Product Code: ETC9956692 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market - Industry Life Cycle |
3.4 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market - Porter's Five Forces |
3.5 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market Revenues & Volume Share, By Procedure Type, 2021 & 2031F |
3.6 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.8 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of liver cancer in the United Kingdom |
4.2.2 Growing awareness about the effectiveness of transarterial chemoembolization (TACE) as a treatment option |
4.2.3 Advancements in technology leading to improved TACE procedures |
4.3 Market Restraints |
4.3.1 High cost associated with TACE procedures |
4.3.2 Limited reimbursement policies for TACE treatments in the UK |
4.3.3 Lack of skilled healthcare professionals specializing in TACE procedures |
5 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market Trends |
6 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market, By Types |
6.1 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market, By Procedure Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Procedure Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Conventional TACE, 2021- 2031F |
6.1.4 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market Revenues & Volume, By DEB-TACE, 2021- 2031F |
6.2 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Unresectable HCC, 2021- 2031F |
6.2.3 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Early-Stage HCC, 2021- 2031F |
6.3 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market, By Product Type |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Chemotherapeutic Agents, 2021- 2031F |
6.3.3 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Radiotherapeutic Agents, 2021- 2031F |
6.3.4 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Drug-eluting Particles, 2021- 2031F |
6.3.5 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Surgical Centers, 2021- 2031F |
6.4.5 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Others, 2021- 2031F |
7 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market Export to Major Countries |
7.2 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market Imports from Major Countries |
8 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market Key Performance Indicators |
8.1 Average waiting time for TACE procedures in the UK |
8.2 Number of hospitals offering TACE treatments |
8.3 Patient satisfaction rates with TACE services |
8.4 Number of research studies or clinical trials on TACE efficacy |
8.5 Percentage of TACE procedures performed by experienced interventional radiologists |
9 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market - Opportunity Assessment |
9.1 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market Opportunity Assessment, By Procedure Type, 2021 & 2031F |
9.2 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.4 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market Opportunity Assessment, By Application, 2021 & 2031F |
10 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market - Competitive Landscape |
10.1 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Transarterial Chemoembolization (TACE) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here